Ignite Creation Date:
2024-05-06 @ 4:42 PM
Last Modification Date:
2024-10-26 @ 2:14 PM
Study NCT ID:
NCT05060627
Status:
RECRUITING
Last Update Posted:
2022-09-08
First Post:
2021-09-17
Brief Title:
Study of Belantamab Mafodotin in Combination With Kd for the Treatment of Relapsed Myeloma Patients Refractory to Lenalidomide
Sponsor:
PETHEMA Foundation
Organization:
PETHEMA Foundation
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-12-20
Start Date Type:
ACTUAL
Primary Completion Date:
2024-05
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-05-30
Completion Date Type:
ESTIMATED
First Submit Date:
2021-09-17
First Submit QC Date:
September 28 2021
Study First Post Date:
2021-09-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-09-05
Last Update Post Date:
2022-09-08
Last Update Post Date Type:
ACTUAL